Biotech · Public company · Houston, TX, US
CNS Pharmaceuticals, Inc.
Ticker CNSP · SEC CIK 0001729427
Track this companyFree. Adds CNS Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline2
- BerubicinPhase 2 · Glioblastoma Multiforme, AdultClinicalTrials.gov · fetched Nov 12, 2026
- LomustinePhase 2 · Glioblastoma Multiforme, AdultClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma MultiformePHASE2 · ACTIVE_NOT_RECRUITING · started May 18, 2021ClinicalTrials.gov NCT04762069 · fetched Nov 12, 2026
SEC filings12
- 8-K · FORM 8-KSEC EDGAR · filed Oct 2, 2026 · fetched Nov 12, 2026
- 10-Q · FORM 10-Q FOR JUN 2026SEC EDGAR · filed Aug 12, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jul 2, 2026 · fetched Nov 12, 2026
- 10-Q · FORM 10-Q FOR MAR 2026SEC EDGAR · filed May 14, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed May 4, 2026 · fetched Nov 12, 2026
- 10-K/A · AMENDMENT #1 TO FORM 10-KSEC EDGAR · filed Apr 30, 2026 · fetched Nov 12, 2026
- 10-K · FORM 10-K FOR DEC 2025SEC EDGAR · filed Mar 31, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Mar 11, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Mar 2, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Feb 17, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Dec 17, 2025 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Nov 21, 2025 · fetched Nov 12, 2026